OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reissued by research analysts at FinnCap in a research report issued on Wednesday.

TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/11/03/finncap-reiterates-corporate-rating-for-optibiotix-health-plc-opti.html.

About OptiBiotix Health PLC

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Stock Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related stocks with our FREE daily email newsletter.